Global Study Finds Child Antibiotic Resistance Rose Across 82 Countries, With Last-Line Failures Seen Rising by 2035
Updated
Updated · The Guardian · Jul 21
Global Study Finds Child Antibiotic Resistance Rose Across 82 Countries, With Last-Line Failures Seen Rising by 2035
2 articles · Updated · The Guardian · Jul 21
Summary
106,581 pediatric infection samples from 82 countries showed antibiotic resistance increased in every region from 2004 to 2022, with babies, intensive-care patients and lower-resource countries hit hardest.
By 2035, resistance to last-line drugs is projected to reach 82% for Acinetobacter baumannii and 35% for Klebsiella, two bacteria linked to severe infections such as sepsis, pneumonia and urinary tract infections.
Researchers said the rise is being driven by frequent and sometimes unregulated antibiotic use, poor sanitation in low-income settings, and broader overuse in healthcare, farming and veterinary care in richer countries.
The study found first-line antibiotic resistance is stabilizing or falling in high-income regions, but lower-resource areas are seeing sharp increases in resistance to critical 'watch' and 'reserve' drugs.
Murdoch Children’s Research Institute and University of Sydney researchers launched the AMR in Kids website to map country- and pathogen-specific risks through 2035, aiming to guide treatment, surveillance and research.
Will the pediatric superbug crisis finally force a global overhaul of antibiotic use in our food supply?
Can AI and wastewater analysis predict the next superbug outbreak in children before it becomes a crisis?
As last-resort drugs fail children, are virus-based therapies and AI-designed antibiotics our next line of defense?
Children at Risk: The Escalating Crisis of Antibiotic Resistance and Global Response Strategies
Overview
Antibiotic resistance in children is rising worldwide and is expected to get much worse in the coming years. Children are especially at risk because their immune systems are less mature, they get more bacterial infections, and they have fewer treatment options. Overuse and misuse of antibiotics, especially powerful last-resort drugs, are making the problem worse, particularly in low- and middle-income countries where sanitation and access to proper healthcare are limited. As first-line antibiotics fail, broader-spectrum drugs are used more often, fueling even more resistance. Tackling this crisis requires global cooperation, better surveillance, new child-friendly medicines, improved diagnostics, and strong public education to protect children’s health now and in the future.